-
1
-
-
35848968871
-
Prevalence of chronic kidney disease in the United States
-
J. Coresh, E. Selvin, L.A. Stevens Prevalence of chronic kidney disease in the United States JAMA 298 17 2007 2038 2047
-
(2007)
JAMA
, vol.298
, Issue.17
, pp. 2038-2047
-
-
Coresh, J.1
Selvin, E.2
Stevens, L.A.3
-
2
-
-
70350219254
-
When to conduct a renal impairment study during drug development: US Food and Drug Administration perspective
-
S.M. Huang, R. Temple, S. Xiao, L. Zhang, L.J. Lesko When to conduct a renal impairment study during drug development: US Food and Drug Administration perspective Clin Pharmacol Ther 86 5 2009 475 479
-
(2009)
Clin Pharmacol Ther
, vol.86
, Issue.5
, pp. 475-479
-
-
Huang, S.M.1
Temple, R.2
Xiao, S.3
Zhang, L.4
Lesko, L.J.5
-
3
-
-
79958811114
-
The definition, classification, and prognosis of chronic kidney disease: A KDIGO Controversies Conference report
-
A.S. Levey, P.E. de Jong, J. Coresh The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report Kidney Int 80 1 2011 17 28
-
(2011)
Kidney Int
, vol.80
, Issue.1
, pp. 17-28
-
-
Levey, A.S.1
De Jong, P.E.2
Coresh, J.3
-
4
-
-
65249178935
-
Kidney function influences warfarin responsiveness and hemorrhagic complications
-
N.A. Limdi, T.M. Beasley, M.F. Baird Kidney function influences warfarin responsiveness and hemorrhagic complications J Am Soc Nephrol 20 2009 912 921
-
(2009)
J Am Soc Nephrol
, vol.20
, pp. 912-921
-
-
Limdi, N.A.1
Beasley, T.M.2
Baird, M.F.3
-
5
-
-
65649142017
-
A new equation to estimate glomerular filtration rate
-
A.S. Levey, L.A. Stevens, C.H. Schmid A new equation to estimate glomerular filtration rate Ann Intern Med 150 9 2009 604 612
-
(2009)
Ann Intern Med
, vol.150
, Issue.9
, pp. 604-612
-
-
Levey, A.S.1
Stevens, L.A.2
Schmid, C.H.3
-
6
-
-
0027457034
-
Risk factors for complications of chronic anticoagulation A multicenter study. Warfarin Optimized Outpatient Follow-up Study Group
-
S.D. Fihn, M. McDonell, D. Martin Risk factors for complications of chronic anticoagulation A multicenter study. Warfarin Optimized Outpatient Follow-up Study Group Ann Intern Med 118 7 1993 511 520
-
(1993)
Ann Intern Med
, vol.118
, Issue.7
, pp. 511-520
-
-
Fihn, S.D.1
McDonell, M.2
Martin, D.3
-
7
-
-
0002181512
-
Multiple events per subject
-
T.M. Therneau, P.M. Grambsch, 1st ed. Springer-Verlag New York, NY
-
T.M. Therneau, P.M. Grambsch Multiple events per subject T.M. Therneau, P.M. Grambsch, Modeling Survival Data: Extending the Cox Model (Statistics for Biology and Health) 1st ed. 2001 Springer-Verlag New York, NY 169 229
-
(2001)
Modeling Survival Data: Extending the Cox Model (Statistics for Biology and Health)
, pp. 169-229
-
-
Therneau, T.M.1
Grambsch, P.M.2
-
8
-
-
38349126516
-
Influence of CYP2C9 and VKORC1 1173C/T genotype on the risk of hemorrhagic complications in African-American and European-American patients on warfarin
-
N.A. Limdi, G. McGwin, J.A. Goldstein Influence of CYP2C9 and VKORC1 1173C/T genotype on the risk of hemorrhagic complications in African-American and European-American patients on warfarin Clin Pharmacol Ther 83 2 2008 312 321
-
(2008)
Clin Pharmacol Ther
, vol.83
, Issue.2
, pp. 312-321
-
-
Limdi, N.A.1
McGwin, G.2
Goldstein, J.A.3
|